Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 12, 2013, Pages 1583-1592

  Manos, J ^a   Hu, H ^a,e   Rose, B R ^a   Wainwright, C E ^b   Zablotska, I B ^c   Cheney, J ^b   Turnbull, L ^d   Whitchurch, C B ^d   Grimwood, K ^b   Harmer, C ^a   Anuj, S N ^b   Harbour, C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^e MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; ELASTASE; HEMOLYSIN; PHOSPHOLIPASE C; PROTEINASE; PYOCYANINE; PYOVERDINE; RHAMNOLIPID; TIMENTIN; TOBRAMYCIN; VIRULENCE FACTOR;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL PHENOMENA AND FUNCTIONS; BACTERIAL VIRULENCE; BACTERIUM COLONY; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE DURATION; DISEASE EXACERBATION; FEMALE; GENDER; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN CELL; INFANT; LUNG CLEARANCE; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ONSET AGE; OROPHARYNX; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RANDOMIZED CONTROLLED TRIAL; SWIMMING MOTILITY; THROAT CULTURE; TWITCHING MOTILITY;

BACTERIAL PROTEINS; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; GENOTYPE; HUMANS; INFANT; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VIRULENCE FACTORS;

EID: 84887998802     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-1916-7     Document Type: Article

References (39)

1. Lee TW, Brownlee KG, Denton M, Littlewood JM, Conway SP (2004) Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center. Pediatr Pulmonol 37:104-110
2. Williams BJ, Dehnbostel J, Blackwell TS (2010) Pseudomonas aeruginosa: host defence in lung diseases. Respirology 15:1037-1056
3. Goodman AL, Kulasekara B, Rietsch A, Boyd D, Smith RS, Lory S (2004) A signaling network reciprocally regulates genes associated with acute infection and chronic persistence in Pseudomonas aeruginosa. Dev Cell 7:745-754
4. Oberhardt MA, Goldberg JB, Hogardt M, Papin JA (2010) Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection. J Bacteriol 192:5534-5548
5. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, D'Argenio DA, Miller SI, Ramsey BW, Speert DP, Moskowitz SM, Burns JL, Kaul R, Olson MV (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103:8487-8492
6. Bianconi I, Milani A, Cigana C, Paroni M, Levesque RC, Bertoni G, Bragonzi A (2011) Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infection. PLoS Pathog 7:e1001270
7. Hu H, Harmer C, Anuj S, Wainwright CE, Manos J, Cheney J, Harbour C, Zablotska I, Turnbull L, Whitchurch CB, Grimwood K, Rose B; FBAL study investigators (2013) Type 3 secretion system effector genotype and secretion phenotype of longitudinally collected Pseudomonas aeruginosa isolates from young children diagnosed with cystic fibrosis following newborn screening. Clin Microbiol Infect 19:266-272
8. Wainwright CE, Vidmar S, Armstrong DS, Byrnes CA, Carlin JB, Cheney J, Cooper PJ, Grimwood K, Moodie M, Robertson CF, Tiddens HA; ACFBAL Study Investigators (2011) Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial. JAMA 306:163-171
9. Kidd TJ, Ramsay KA, Hu H, Bye PT, Elkins MR, Grimwood K, Harbour C, Marks GB, Nissen MD, Robinson PJ, Rose BR, Sloots TP, Wainwright CE, Bell SC; ACPinCF Investigators (2009) Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients. J Clin Microbiol 47:1503-1509
10. Anthony M, Rose B, Pegler MB, Elkins M, Service H, Thamotharampillai K, Watson J, Robinson M, Bye P, Merlino J, Harbour C (2002) Genetic analysis of Pseudomonas aeruginosa isolates from the sputa of Australian adult cystic fibrosis patients. J Clin Microbiol 40:2772-2778
11. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233-2239
12. Higashihara TAS (1984) Isolation of pyocyanin produced by hydrocarbon-assimilating bacteria and its taxonomic characteristics. Report Ferment Res Inst 63:65-78
13. Vinckx T, Wei Q, Matthijs S, Cornelis P (2010) The Pseudomonas aeruginosa oxidative stress regulator OxyR influences production of pyocyanin and rhamnolipids: protective role of pyocyanin. Microbiology 156:678-686
14. Essar DW, Eberly L, Hadero A, Crawford IP (1990) Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications. J Bacteriol 172:884-900
15. King EO, Ward MK, Raney DE (1954) Two simple media for the demonstration of pyocyanin and fluorescin. J Lab Clin Med 44:301-307
16. Hohnadel D, Haas D, Meyer J-M (1986) Mapping of mutations affecting pyoverdine production in Pseudomonas aeruginosa. FEMS Microbiol Lett 36:195-199
17. Pomerantsev AP, Kalnin KV, Osorio M, Leppla SH (2003) Phosphatidylcholine-specific phospholipase C and sphingomyelinase activities in bacteria of the Bacillus cereus group. Infect Immun 71:6591-6606
18. Rossignol G, Merieau A, Guerillon J, Veron W, Lesouhaitier O, Feuilloley MG, Orange N (2008) Involvement of a phospholipase C in the hemolytic activity of a clinical strain of Pseudomonas fluorescens. BMC Microbiol 8:189
19. Kidd TJ, Ramsay KA, Hu H, Marks GB, Wainwright CE, Bye PT, Elkins MR, Robinson PJ, Rose BR, Wilson JW, Grimwood K, Bell SC; ACPinCF Investigator Group (2013) Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J 41:1091-1100
20. Bjarnsholt T, Jensen PØ, Jakobsen TH, Phipps R, Nielsen AK, Rybtke MT, Tolker-Nielsen T, Givskov M, Høiby N, Ciofu O; Scandinavian Cystic Fibrosis Study Consortium (2010) Quorum sensing and virulence of Pseudomonas aeruginosa during lung infection of cystic fibrosis patients. PLoS One 5:e10115
21. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, Di Serio C, Döring G, Tümmler B (2009) Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180:138-145
22. Lorè NI, Cigana C, De Fino I, Riva C, Juhas M, Schwager S, Eberl L, Bragonzi A (2012) Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts. PLoS One 7:e35648
23. Amiel E, Lovewell RR, O'Toole GA, Hogan DA, Berwin B (2010) Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect Immun 78:2937-2945
24. De Vos D, De Chial M, Cochez C, Jansen S, Tümmler B, Meyer JM, Cornelis P (2001) Study of pyoverdine type and production by Pseudomonas aeruginosa isolated from cystic fibrosis patients: prevalence of type II pyoverdine isolates and accumulation of pyoverdine-negative mutations. Arch Microbiol 175:384-388
25. Pacheco GJ, Reis RS, Fernandes AC, da Rocha SL, Pereira MD, Perales J, Freire DM (2012) Rhamnolipid production: effect of oxidative stress on virulence factors and proteome of Pseudomonas aeruginosa PA1. Appl Microbiol Biotechnol 95:1519-1529
26. Morris JD, Hewitt JL, Wolfe LG, Kamatkar NG, Chapman SM, Diener JM, Courtney AJ, Leevy WM, Shrout JD (2011) Imaging and analysis of Pseudomonas aeruginosa swarming and rhamnolipid production. Appl Environ Microbiol 77:8310-8317
27. Abdel-Mawgoud AM, Lépine F, Déziel E (2010) Rhamnolipids: diversity of structures, microbial origins and roles. Appl Microbiol Biotechnol 86:1323-1336
28. Boles BR, Thoendel M, Singh PK (2005) Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Mol Microbiol 57:1210-1223
29. Stehling EG, Silveira WD, Leite Dda S (2008) Study of biological characteristics of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis and from patients with extra-pulmonary infections. Braz J Infect Dis 12:86-88
30. Reiling SA, Jansen JA, Henley BJ, Singh S, Chattin C, Chandler M, Rowen DW (2005) Prc protease promotes mucoidy in mucA mutants of Pseudomonas aeruginosa. Microbiology 151:2251-2261
31. Wargo MJ, Gross MJ, Rajamani S, Allard JL, Lundblad LK, Allen GB, Vasil ML, Leclair LW, Hogan DA (2011) Hemolytic phospholipase C inhibition protects lung function during Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 184:345-354
32. FitzSimmons SC (1993) The changing epidemiology of cystic fibrosis. J Pediatr 122:1-9
33. Grimwood K, Semple RA, Rabin HR, Sokol PA, Woods DE (1993) Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis. Pediatr Pulmonol 15:135-139
34. Bjarnsholt T, Jensen PØ, Fiandaca MJ, Pedersen J, Hansen CR, Andersen CB, Pressler T, Givskov M, Høiby N (2009) Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol 44:547-558
35. Klausen M, Heydorn A, Ragas P, Lambertsen L, Aaes-Jørgensen A, Molin S, Tolker-Nielsen T (2003) Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol 48:1511-1524
36. Murray TS, Ledizet M, Kazmierczak BI (2010) Swarming motility, secretion of type 3 effectors and biofilm formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolates. J Med Microbiol 59:511-520
37. Hansen SK, Rau MH, Johansen HK, Ciofu O, Jelsbak L, Yang L, Folkesson A, Jarmer HØ, Aanæs K, von Buchwald C, Høiby N, Molin S (2012) Evolution and diversification of Pseudomonas aeruginosa in the paranasal sinuses of cystic fibrosis children have implications for chronic lung infection. ISME J 6:31-45
38. Johansen HK, Aanaes K, Pressler T, Nielsen KG, Fisker J, Skov M, Høiby N, von Buchwald C (2012) Colonisation and infection of the paranasal sinuses in cystic fibrosis patients is accompanied by a reduced PMN response. J Cyst Fibros 11:525-531
39. Burke V, Robinson JO, Richardson CJ, Bundell CS (1991) Longitudinal studies of virulence factors of Pseudomonas aeruginosa in cystic fibrosis. Pathology 23:145-148